Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023

SELL
$94.73 - $105.13 $31,260 - $34,692
-330 Reduced 1.31%
24,811 $2.53 Million
Q2 2023

Jul 27, 2023

SELL
$92.52 - $104.91 $4,811 - $5,455
-52 Reduced 0.21%
25,141 $2.54 Million
Q1 2023

May 12, 2023

BUY
$80.03 - $92.81 $117,564 - $136,337
1,469 Added 6.19%
25,193 $2.32 Million
Q4 2022

Feb 08, 2023

SELL
$75.55 - $92.52 $8,914 - $10,917
-118 Reduced 0.49%
23,724 $2.15 Million
Q3 2022

Nov 09, 2022

SELL
$74.61 - $87.26 $84,309 - $98,603
-1,130 Reduced 4.53%
23,842 $1.81 Million
Q2 2022

Aug 11, 2022

SELL
$80.52 - $93.75 $8,132 - $9,468
-101 Reduced 0.4%
24,972 $2.11 Million
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $42,938 - $48,572
536 Added 2.18%
25,073 $2.2 Million
Q4 2021

Feb 09, 2022

BUY
$79.7 - $88.13 $712,757 - $788,146
8,943 Added 57.35%
24,537 $2.15 Million
Q3 2021

Oct 26, 2021

SELL
$81.78 - $95.14 $5,724 - $6,659
-70 Reduced 0.45%
15,594 $1.28 Million
Q2 2021

Jul 14, 2021

BUY
$85.24 - $94.15 $21,310 - $23,537
250 Added 1.62%
15,664 $1.43 Million
Q1 2021

Apr 26, 2021

SELL
$83.5 - $98.47 $2,087 - $2,461
-25 Reduced 0.16%
15,414 $1.32 Million
Q4 2020

Feb 10, 2021

BUY
$78.07 - $94.43 $1.21 Million - $1.46 Million
15,439 New
15,439 $1.46 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Connolly Sarah T. Portfolio

Follow Connolly Sarah T. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connolly Sarah T., based on Form 13F filings with the SEC.

News

Stay updated on Connolly Sarah T. with notifications on news.